메뉴 건너뛰기




Volumn 10, Issue 15, 2003, Pages 1441-1468

Preterm labour: An overview of current and emerging therapeutics

Author keywords

Calcium channel blocker; Oxytocin antagonist; Parturition; Preterm labour; Prostaglandin antagonist; Tocolytic; Uterine contractility; 2 adrenergic agonist

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; ADALAT CC; ALCOHOL; AMLODIPINE; AMPICILLIN; ANTIBIOTIC AGENT; ATOSIBAN; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUPHENINE; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DYNACIRE; ERYTHROMYCIN; FELODIPINE; FENOTEROL; INDOMETACIN; ISOXSUPRINE; ISRADIPINE; MAGNESIUM SULFATE; NICARDIPINE; NIFEDIPINE; NORVASE; ORCIPRENALINE; OXYTOCIN ANTAGONIST; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SALBUTAMOL; TERBUTALINE; UNINDEXED DRUG; UTERUS SPASMOLYTIC AGENT; VERAPAMIL;

EID: 0042810958     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867033457331     Document Type: Review
Times cited : (32)

References (339)
  • 13
    • 0026654964 scopus 로고
    • The treatment of preterm labour with beta-adrenergic agonist ritodrine
    • Canadian Preterm Labour Investigators Group
    • Canadian Preterm Labour Investigators Group. The treatment of preterm labour with beta-adrenergic agonist ritodrine. New Engl. J. Med., 1992, 327, 308.
    • (1992) New Engl. J. Med. , vol.327 , pp. 308
  • 27
    • 0042544251 scopus 로고    scopus 로고
    • New York, Harper and Row
    • Rybacki, J.J.; Long, J.W. New York, Harper and Row, 1998.
    • (1998)
    • Rybacki, J.J.1    Long, J.W.2
  • 65
    • 84921430858 scopus 로고    scopus 로고
    • Antibiotics for preterm labour with intact membranes
    • Cochrane Database Syst. Rev. Oxford: Update Software
    • King, J.; Flenady, V. Antibiotics for preterm labour with intact membranes. Cochrane Database Syst Rev, The Cochrane Library; Issue 1. Oxford: Update Software, 2000.
    • (2000) The Cochrane Library , Issue.1
    • King, J.1    Flenady, V.2
  • 77
    • 0025868648 scopus 로고
    • Fries, J.F. J. Rheumatol., 1991, 18(Suppl 28), 6.
    • (1991) J. Rheumatol. , vol.18 , Issue.SUPPL. 28 , pp. 6
    • Fries, J.F.1
  • 171
  • 177
    • 0001859511 scopus 로고
    • Mitchell, M.D., Ed.; CRC Press: Boca Raton
    • Keirse, M.J.N.C. In Eicosanoids and Reproduction; Mitchell, M.D., Ed.; CRC Press: Boca Raton, 1990; pp. 199-222.
    • (1990) Eicosanoids and Reproduction , pp. 199-222
    • Keirse, M.J.N.C.1
  • 229
    • 0020987004 scopus 로고
    • For a review, see (Neurohypophysis: Struct., Funct. Control)
    • For a review, see Manning, M.; Sawyer, W.H. Progr. Brain Res., 1983, 60(Neurohypophysis: Struct., Funct. Control), 367.
    • (1983) Progr. Brain Res. , vol.60 , pp. 367
    • Manning, M.1    Sawyer, W.H.2
  • 245
    • 85039654984 scopus 로고    scopus 로고
    • Patent JP-14138098 (Mitsubishi Pharma Corp.;)
    • Patent JP-14138098 (Mitsubishi Pharma Corp.; 2002).
    • (2002)
  • 246
    • 0024509653 scopus 로고
    • See also patents EP-00273645 (Medical College of Ohio, Columbia University; 1988), EP-00189326 (Medical College of Ohio, Columbia University; 1986)
    • Manning, M.; Kruszynski, M.; Bankowski, K.; Olma, A.; Lammek, B.; Cheng, L.L.; Klis, W.A.; Seto, J.; Haldar, J.; Sawyer, W.H. J. Med. Chem., 1989, 32, 382. See also patents EP-00273645 (Medical College of Ohio, Columbia University; 1988), EP-00189326 (Medical College of Ohio, Columbia University; 1986).
    • (1989) J. Med. Chem. , vol.32 , pp. 382
    • Manning, M.1    Kruszynski, M.2    Bankowski, K.3    Olma, A.4    Lammek, B.5    Cheng, L.L.6    Klis, W.A.7    Seto, J.8    Haldar, J.9    Sawyer, W.H.10
  • 264
    • 0028881589 scopus 로고
    • See also patents EP-00486280 (Merck & Co. Inc.; 1992), EP-00533243 (Merck & Co. Inc.; 1993), EP-00533244 (Merck & Co. Inc.; 1993), WO-09514025 (Merck & Co. Inc.; 1995), US-05670509 (Merck & Co. Inc.; 1997)
    • Hobbs, D.W.; Gould, N.P.; Hoffman, J.B.; Clineschmidt, B.V.; Pettibone, D.J.; Veber, D.F.; Freidinger, R.M. Bioorg. Med. Chem. Lett., 1995, 5, 119. See also patents EP-00486280 (Merck & Co. Inc.; 1992), EP-00533243 (Merck & Co. Inc.; 1993), EP-00533244 (Merck & Co. Inc.; 1993), WO-09514025 (Merck & Co. Inc.; 1995), US-05670509 (Merck & Co. Inc.; 1997).
    • (1995) Bioorg. Med. Chem. Lett. , vol.5 , pp. 119
    • Hobbs, D.W.1    Gould, N.P.2    Hoffman, J.B.3    Clineschmidt, B.V.4    Pettibone, D.J.5    Veber, D.F.6    Freidinger, R.M.7
  • 266
    • 0028506407 scopus 로고
    • See also patents EP-00532097 (Merck & Co. Inc.; 1993), EP-00533240 (Merck & Co. Inc.; 1993), EP-00533241 (Merck & Co. Inc.; 1993), EP-00533242 (Merck & Co. Inc.; 1993), WO-09502587 (Merck & Co. Inc.; 1995), WO-09525443 (Merck & Co. Inc.; 1995), GB-02326639 (Merck & Co. Inc.; 1998)
    • Williams, P.D.; Ball, R.G.; Clineschmidt, B.V.; Culberson, J.C.; Erb, J.M.; Freidinger, R.M.; Pawluczyk, J.M.; Perlow, D.S.; Pettibone, D.J.; Veber, D.F. Bioorg. Med. Chem., 1994, 2, 971. See also patents EP-00532097 (Merck & Co. Inc.; 1993), EP-00533240 (Merck & Co. Inc.; 1993), EP-00533241 (Merck & Co. Inc.; 1993), EP-00533242 (Merck & Co. Inc.; 1993), WO-09502587 (Merck & Co. Inc.; 1995), WO-09525443 (Merck & Co. Inc.; 1995), GB-02326639 (Merck & Co. Inc.; 1998).
    • (1994) Bioorg. Med. Chem. , vol.2 , pp. 971
    • Williams, P.D.1    Ball, R.G.2    Clineschmidt, B.V.3    Culberson, J.C.4    Erb, J.M.5    Freidinger, R.M.6    Pawluczyk, J.M.7    Perlow, D.S.8    Pettibone, D.J.9    Veber, D.F.10
  • 273
    • 0028787915 scopus 로고
    • See also patents US-05356904 (Merck & Co. Inc.; 1994), WO-09502405 (Merck & Co. Inc.; 1995), WO-09519773 (Merck & Co. Inc.; 1995), WO-09622775 (Merck & Co. Inc.; 1996), WO-09725992 (Merck & Co. Inc.; 1997)
    • Williams, P.D.; Clineschmidt, B.V.; Erb, J.M.; Freidinger, R.M.; Guidotti, M.T.; Lis, E.V.; Pawluczyk, J.M.; Pettibone, D.J.; Reiss, D.R.; Veber, D.F. J. Med. Chem., 1995, 38, 4634. See also patents US-05356904 (Merck & Co. Inc.; 1994), WO-09502405 (Merck & Co. Inc.; 1995), WO-09519773 (Merck & Co. Inc.; 1995), WO-09622775 (Merck & Co. Inc.; 1996), WO-09725992 (Merck & Co. Inc.; 1997).
    • (1995) J. Med. Chem. , vol.38 , pp. 4634
    • Williams, P.D.1    Clineschmidt, B.V.2    Erb, J.M.3    Freidinger, R.M.4    Guidotti, M.T.5    Lis, E.V.6    Pawluczyk, J.M.7    Pettibone, D.J.8    Reiss, D.R.9    Veber, D.F.10
  • 284
    • 0043045122 scopus 로고    scopus 로고
    • Patents WO-0172705 (ARS Holding NV;) WO-0232864 (ARS Holding NV; 2002), WO-02074741 (ARS Holding NV; 2002)
    • Patents WO-0172705 (ARS Holding NV; 2001), WO-0232864 (ARS Holding NV; 2002), WO-02074741 (ARS Holding NV; 2002).
    • (2001)
  • 285
    • 0027296317 scopus 로고
    • See also patents EP-00469984 (Sanofi-Synthelabo; 1992), EP-00636609 (Sanofi-Synthelabo; 1995), EP-00694536 (Sanofi-Synthelabo; 1996), WO-09715556 (Sanofi-Synthelabo; 1997), WO-00174775 (Sanofi-Synthelabo; 2001), etc
    • Serradeil-Le Gal, C.; Wagnon, J.; Garcia, C.; Lacour, C.; Guiraudou, P.; Christophe, B.; Villanova, G.; Nisato, D.; Maffrand, J. P. J. Clin. Invest., 1993, 92, 224. See also patents EP-00469984 (Sanofi-Synthelabo; 1992), EP-00636609 (Sanofi-Synthelabo; 1995), EP-00694536 (Sanofi-Synthelabo; 1996), WO-09715556 (Sanofi-Synthelabo; 1997), WO-00174775 (Sanofi-Synthelabo; 2001), etc.
    • (1993) J. Clin. Invest. , vol.92 , pp. 224
    • Serradeil-Le Gal, C.1    Wagnon, J.2    Garcia, C.3    Lacour, C.4    Guiraudou, P.5    Christophe, B.6    Villanova, G.7    Nisato, D.8    Maffrand, J.P.9
  • 290
    • 85039658220 scopus 로고    scopus 로고
    • Patents WO-00174775 (Sanofi-Synthelabo;); WO-09715556 (Sanofi-Synthelabo; 1997), EP-00694536 (Sanofi-Synthelabo; 1996), etc
    • Patents WO-00174775 (Sanofi-Synthelabo; 2001); WO-09715556 (Sanofi-Synthelabo; 1997), EP-00694536 (Sanofi-Synthelabo; 1996), etc.
    • (2001)
  • 296
    • 85039662085 scopus 로고    scopus 로고
    • Patent WO-09839325 (Yamanouchi Pharmaceutical Co. Ltd.;). See also patent WO-09506035 (Yamanouchi Pharmaceutical Co. Ltd.; 1995)
    • Patent WO-09839325 (Yamanouchi Pharmaceutical Co. Ltd.; 1998). See also patent WO-09506035 (Yamanouchi Pharmaceutical Co. Ltd.; 1995).
    • (1998)
  • 303
    • 85039655452 scopus 로고    scopus 로고
    • Patents JP-12351768 (Otsuka Pharmaceutical Co. Ltd.;), WO-09722591 (Otsuka Pharmaceutical Co. Ltd.; 1997), WO-09534540 (Otsuka Pharmaceutical Co. Ltd.; 1995), WO-09408582 (Otsuka Pharmaceutical Co. Ltd.; 1994), WO-09404525 (Otsuka Pharmaceutical Co. Ltd.; 1994), WO-09401113 (Otsuka Pharmaceutical Co. Ltd.; 1994)
    • Patents JP-12351768 (Otsuka Pharmaceutical Co. Ltd.; 2000), WO-09722591 (Otsuka Pharmaceutical Co. Ltd.; 1997), WO-09534540 (Otsuka Pharmaceutical Co. Ltd.; 1995), WO-09408582 (Otsuka Pharmaceutical Co. Ltd.; 1994), WO-09404525 (Otsuka Pharmaceutical Co. Ltd.; 1994), WO-09401113 (Otsuka Pharmaceutical Co. Ltd.; 1994).
    • (2000)
  • 308
    • 85039658909 scopus 로고    scopus 로고
    • Patents WO-09747624 (American Cyanamid Co./AHP;), WO-09747625 (American Cyanamid Co./AHP; 1997), WO-09622282 (American Cyanamid Co./AHP; 1996), WO-09622294 (American Cyanamid Co./AHP; 1996), WO-09622293 (American Cyanamid Co./AHP; 1996), US-05521173 (Wyeth; 1996)
    • Patents WO-09747624 (American Cyanamid Co./AHP; 1997), WO-09747625 (American Cyanamid Co./AHP; 1997), WO-09622282 (American Cyanamid Co./AHP; 1996), WO-09622294 (American Cyanamid Co./AHP; 1996), WO-09622293 (American Cyanamid Co./AHP; 1996), US-05521173 (Wyeth; 1996).
    • (1997)
  • 317
    • 0034048090 scopus 로고    scopus 로고
    • Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: A multicenter effectiveness and safety study
    • The Canadian and Israeli Atosiban Study Groups
    • The Canadian and Israeli Atosiban Study Groups. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: a multicenter effectiveness and safety study. Am. J. Obst. Gynecol., 2000, 182, 1191.
    • (2000) Am. J. Obst. Gynecol. , vol.182 , pp. 1191
  • 318
    • 0035024390 scopus 로고    scopus 로고
    • The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labour. A randomized, double-blind, controlled study
    • The European Atosiban Study Group
    • The European Atosiban Study Group. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labour. A randomized, double-blind, controlled study. Acta Obstet. Gynecol. Scand., 2001, 80, 413.
    • (2001) Acta Obstet. Gynecol. Scand. , vol.80 , pp. 413
  • 319
    • 0035487869 scopus 로고    scopus 로고
    • Treatment of preterm labour with the oxytocin antagonist atosiban: A double-blind, randomized, controlled comparison with salbutamol
    • The French/Australian Atosiban Study Group
    • The French/Australian Atosiban Study Group. Treatment of preterm labour with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 98, 177.
    • (2001) Eur. J. Obstet. Gynecol. Reprod. Biol. , vol.98 , pp. 177
  • 320
    • 0035108210 scopus 로고    scopus 로고
    • Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour
    • The Worldwide Atosiban versus Beta-agonists Study Group
    • The Worldwide Atosiban versus Beta-agonists Study Group. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. Brit. J. Obstet. Gynecol., 2001, 108, 133.
    • (2001) Brit. J. Obstet. Gynecol. , vol.108 , pp. 133
  • 337
    • 85039661974 scopus 로고    scopus 로고
    • Patent WO-00222621 (Allergan Sales Inc.;)
    • Patent WO-00222621 (Allergan Sales Inc.; 2002)
    • (2002)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.